Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning! - 2IDF strikes Hamas terror base in Lebanon, Health Ministry says 11 killed
- 3Skeleton of famed musketeer possibly found in Dutch church
- 4UK can legally stop shadow fleet tankers, ministers believe
- 5Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- The most effective method to Go Down Abundance through Ages with Disc Rates
- Trump says Cuba is 'ready to fall' after capture of Venezuela's Maduro
- Step by step instructions to Prepare with Senior Protection for Inward feeling of harmony.
- Palestinian infant freezes to death in Gaza as Israel keeps blocking aid
- Select Your Go-To Bluetooth Earphones
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
- Scientists reveal earliest evidence for shifting of Earth’s crust
- Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
- Orbán orders stop to gas deliveries to Ukraine via Hungary from July
